P1071: COMBINATION OF PD-1 INHIBITION WITH IMMUNOMODULATORY DRUG TREATMENT IN HODGKIN AND LARGE B-CELL LYMPHOMA: RESULTS FROM A PHASE I/II STUDY

• David Bond,
• Vedat Yildiz,
• Lai Wei,
• John Reneau,
• Yazeed Sawalha,
• Beth Christian,
• Jonathan Brammer,
• Jean Koff,
• Narendranath Epperla,
• Aubree Dendorfer,
• Lily Yang,
• Baiocchi Robert,
• Timothy Voorhees,
• Audrey Sigmund,
• Walter Hanel,
• Polina Shindiapina,
• Nathan Denlinger,
• Sam Penza,
• Samantha Jaglowski,
• Evandro Bezerra,
• Lapo Alinari,
• Kristie Blum,
• Kami Maddocks

Affiliations

David Bond

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Vedat Yildiz

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Lai Wei

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

John Reneau

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Yazeed Sawalha

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Beth Christian

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Jonathan Brammer

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Jean Koff

2 Emory University School of Medicine, Atlanta, United States

Narendranath Epperla

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Aubree Dendorfer

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Lily Yang

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Baiocchi Robert

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Timothy Voorhees

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Audrey Sigmund

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Walter Hanel

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Polina Shindiapina

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Nathan Denlinger

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Sam Penza

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Samantha Jaglowski

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Evandro Bezerra

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Lapo Alinari

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States

Kristie Blum

2 Emory University School of Medicine, Atlanta, United States

Kami Maddocks

1 James Cancer Hospital and Solove Research Institute, Department of Internal Medicine, Division of Hematology, Columbus, United States